Bioceres Crop Solutions Corp. (BIOX) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BIOX Revenue Growth
Revenue Breakdown
BIOX's revenue distribution by segment and geography
By Geography
BIOX Revenue Analysis (2017–2025)
As of May 8, 2026, Bioceres Crop Solutions Corp. (BIOX) generated trailing twelve-month (TTM) revenue of $318.2 million, reflecting significant decline in growth of -16.4% year-over-year. The most recent quarter (Q1 2026) recorded $77.4 million in revenue, up 4.1% sequentially.
Looking at the longer-term picture, BIOX's 5-year compound annual growth rate (CAGR) stands at +14.1%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $464.8 million in 2024.
When compared to Basic Materials sector peers including PGEN (+59.2% YoY), FMC (-16.6% YoY), and CTVA (+6.3% YoY), BIOX has underperformed the peer group in terms of revenue growth. Compare BIOX vs PGEN →
BIOX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BIOXCurrent | $318M | -16.4% | +14.1% | -1.1% | |
 PGEN | $4M | +59.2% | -34.3% | -3440.2% | |
 FMC | $3.5B | -16.6% | -5.7% | -54.4% | |
 CTVA | $17.4B | +6.3% | +4.1% | 15.1% | |
 AVD | $515M | -1.0% | +2.3% | 1.3% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% |
BIOX Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $333.3M | -28.3% | $130.2M | 39.1% | $-3,700,000 | -1.1% |
| 2024 | $464.8M | +10.8% | $181.6M | 39.1% | $44.8M | 9.6% |
| 2023 | $419.4M | +27.7% | $180.2M | 43.0% | $54.2M | 12.9% |
| 2022 | $328.5M | +58.9% | $126.4M | 38.5% | $39.9M | 12.1% |
| 2021 | $206.7M | +19.9% | $90.9M | 44.0% | $38.4M | 18.6% |
| 2020 | $172.4M | +7.5% | $79.5M | 46.1% | $39.1M | 22.7% |
| 2019 | $160.3M | +20.1% | $73.6M | 45.9% | $32.1M | 20.0% |
| 2018 | $133.5M | +42.5% | $56.4M | 42.2% | $15.7M | 11.8% |
| 2017 | $93.7M | - | $33.8M | 36.1% | $-706,924 | -0.8% |
See BIOX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BIOX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BIOX vs LIN
Side-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonBIOX — Frequently Asked Questions
Quick answers to the most common questions about buying BIOX stock.
Is BIOX's revenue growth accelerating or slowing?
BIOX revenue declined -16.4% year-over-year, contrasting with the 5-year CAGR of +14.1%. TTM revenue fell to $318M. This reverses the prior growth trend.
What is BIOX's long-term revenue growth rate?
Bioceres Crop Solutions Corp.'s 5-year revenue CAGR of +14.1% reflects the variable expansion pattern. Current YoY growth of -16.4% is below this long-term average.
How is BIOX's revenue distributed by segment?
BIOX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.